Comparative Efficacy And Side Effects Of Alemtuzumab Versus Basiliximab As Induction Agent In Lung Transplantation

被引:0
|
作者
Kolman, D. [1 ]
Shapiro, W. [1 ]
Zhao, H. [1 ]
Butler-LeBair, M. [1 ]
Patel, N. [1 ]
Shiose, A. [1 ]
Toyoda, Y. [1 ]
Criner, G. J. [1 ]
Cordova, F. C. [1 ]
机构
[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5168
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial
    Haynes, Richard
    Harden, Paul
    Judge, Parminder
    Blackwell, Lisa
    Emberson, Jonathan
    Landray, Martin J.
    Baigent, Colin
    Friend, Peter J.
    LANCET, 2014, 384 (9955): : 1684 - 1690
  • [32] An Analysis of Lymphocyte Phenotype After Steroid Avoidance With Either Alemtuzumab or Basiliximab Induction in Renal Transplantation
    Cherukuri, A.
    Salama, A. D.
    Carter, C.
    Smalle, N.
    McCurtin, R.
    Hewitt, E. W.
    Hernandez-Fuentes, M.
    Clark, B.
    Baker, R. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (04) : 919 - 931
  • [33] Opportunistic Infections After Induction With Alemtuzumab or Basiliximab: A 3-Year Kidney Transplantation Experience
    Florescu, Diana F.
    Seaman, Jonathan A.
    Kalil, Andre C.
    Qiu, Fang
    Bremers, Douglas
    Westphal, Scott G.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (03) : 1058 - 1063
  • [34] Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression:: Efficacy and safety
    Kyllonen, Lauri E.
    Eklund, Bjorn H.
    Pesonen, Eero J.
    Salmela, Kaija T.
    TRANSPLANTATION, 2007, 84 (01) : 75 - 82
  • [35] Infective Complications after Renal Transplantation - A Single Centre Experience Comparing Alemtuzumab to Basiliximab Induction.
    Czajka, R.
    Smith, M. Welberry
    Gittus, M.
    Lindley, E.
    Vernon, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 734 - 735
  • [36] Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results
    Kaufman, DB
    Leventhal, JR
    Axelrod, D
    Gallon, LG
    Parker, MA
    Stuart, FP
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2539 - 2548
  • [37] Induction Therapy in Simultaneous Pancreas-Kidney Transplantation: Thymoglobulin Versus Basiliximab
    Fernandez-Burgos, I.
    Montiel Casado, M. C.
    Perez-Daga, J. A.
    Aranda-Narvaez, J. M.
    Sanchez-Parez, B.
    Leon-Diaz, F. J.
    Cabello-Diaz, M.
    Rodriguez-Burgos, D.
    Hernandez-Marrero, D.
    Santoyo-Santoyo, J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 120 - 122
  • [38] EFFECTIVENESS OF INDUCTION THERAPY FOR RENAL TRANSPLANTATION WITH ALEMTUZUMAB COMPARED WITH CONVENTIONAL THERAPY WITH BASILIXIMAB AT ONE YEAR FOLLOW UP
    Agudelo, Yuli
    Reino, Alberto
    Rodelo, Joaquin
    Hernandez, Gilma
    Garcia, Alvaro
    Henao, Jorge
    Ustariz, Jorge
    Tobon, Juan C.
    Palacios, Dabely
    Arbelaez, Mario
    TRANSPLANT INTERNATIONAL, 2013, 26 : 83 - 83
  • [39] Long-Term Outcomes after Alemtuzumab Induction in Lung Transplantation
    Shyu, S.
    Dew, M. A.
    Dabbs, A. De Vito
    Crespo, M.
    Zaldonts, D. B.
    Johnson, B. A.
    Studer, S. M.
    Toyoda, Y.
    Bermudez, C. A.
    Hattler, B. G.
    Pilewski, J. M.
    McCurry, K. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S68 - S68
  • [40] Comparison of Short-Term Outcomes of Induction Therapy with Alemtuzumab versus Rabbit Antithymocyte Globulin in Lung Transplantation
    Liu, V.
    Soto-Arenall, M. W.
    Patel, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1141 - 1142